982 - Modeling Contractile Diseases Using Scalable 3D Engineered Muscle Tissues for Drug Discovery

Sunday, April 3, 2022

1:30 PM – 1:50 PM

Room: EB Talks Stage/Exhibit Hall - Pennsylvania Convention Center

Presenter(s)

Shawn Luttrell

Curi Bio

iPSC-based 3D organoid systems are traditionally too complex to utilize in high-throughput toxicity studies. Here, we will discuss a novel platform for highly-parallel measurement of engineered muscle contractility. We demonstrate how this scalable platform can be used in a multiplexed manner across various industry-standard assay modalities.